RP1 has likewise been shown to modulate cholesterol levels and disrupt lipid raft organization, leading to downregulation of P-gp expression and inhibition of Src phosphorylation, thereby reversing the resistance of tumor cells to actinomycin D [50]. Here, RP1 is linked to neoplasm.